Wang Qiqi, Cai Xuan, Li Yun, Zhao Jianhong, Liu Zhiyong, Jiang Yan, Meng Ling, Li Yanming, Pan Shiyang, Ai Xiaoman, Zhang Fang, Li Ruoyu, Zheng Bo, Wan Zhe, Liu Wei
Department of Dermatology and Venereology, Peking University First Hospital, National Clinical Research Center for Skin and Immune Diseases, Research Center for Medical Mycology, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Peking University, Beijing, China.
Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Front Microbiol. 2022 Oct 6;13:1006375. doi: 10.3389/fmicb.2022.1006375. eCollection 2022.
To have a comprehensive understanding of epidemiology and antifungal susceptibilities in pathogenic yeasts, the China Antifungal Resistance Surveillance Trial (CARST-fungi) study was conducted. All yeast isolates were identified by ribosomal DNA sequencing. Antifungal susceptibilities were performed using CLSI M27-A4 broth microdilution method. Sequence and expression level of resistant-related genes in resistant/non-wide-type (NWT) isolates were analyzed. Totally 269 nonduplicate yeast isolates from 261 patients were collected. About half of the yeast isolates (127, 47.2%) were recovered from blood, followed by ascetic fluid (46, 17.1%). remained the most prevalent (120, 44.6%), followed by complex (50, 18.6%), (40, 14.9%), and (36, 13.4%). Fourteen (11.7%) isolates and 1 (2.0%) isolate were resistant/NWT to triazoles. Only 42.5% (17/40) were susceptible/WT to all the triazoles, with 19 (47.5%) isolates NWT to posaconazole and 8 (20%) cross-resistant to triazoles. Among , 20 (55.6%) and 8 (22.2%) isolates were resistant/NWT to voriconazole and posaconazole, respectively, and 4 (10.3%) isolates were cross-resistant to triazoles. Isavuconazole was the most active triazole against common isolates. Except for 2 isolates of cross-resistant to echinocandins which were also NWT to POS and defined as multidrug-resistant, echinocandins exhibit good activity against common species. All isolates were WT to AMB. For less common species, exhibited high MICs to echinocandins and FLC, and 1 isolate of showed high MICs to all the antifungals except AMB. Among triazole-resistant isolates, mutations were detected in 10/14 and 6/23 , while 21/23 showed overexpression. Overexpression of , , and exhibited in 14, 13, and 8 of 25 triazole-resistant isolates, with 5 isolates harboring mutations and 2 echinocandins-resistant isolates harboring S663P mutation in . Overall, the CARST-fungi study demonstrated that although remain the most predominant species, non- species accounted for a high proportion. Triazole-resistance is notable among and . Multidrug-resistant isolates of and less common yeast have been emerging.
为全面了解致病性酵母菌的流行病学和抗真菌药敏情况,开展了中国抗真菌耐药性监测试验(CARST -真菌)研究。所有酵母菌分离株均通过核糖体DNA测序进行鉴定。采用CLSI M27 - A4肉汤微量稀释法进行抗真菌药敏试验。分析耐药/非野生型(NWT)分离株中耐药相关基因的序列和表达水平。共收集了来自261例患者的269株非重复酵母菌分离株。约一半的酵母菌分离株(127株,47.2%)从血液中分离得到,其次是腹水(46株,17.1%)。白色念珠菌仍然是最常见的(120株,44.6%),其次是光滑念珠菌复合体(50株,18.6%)、热带念珠菌(40株,14.9%)和近平滑念珠菌(36株,13.4%)。14株(11.7%)光滑念珠菌分离株和1株(2.0%)克柔念珠菌分离株对三唑类耐药/NWT。仅42.5%(17/40)热带念珠菌对所有三唑类敏感/WT,19株(47.5%)分离株对泊沙康唑NWT,8株(20%)对三唑类交叉耐药。在光滑念珠菌中,分别有20株(55.6%)和8株(22.2%)分离株对伏立康唑和泊沙康唑耐药/NWT,4株(10.3%)分离株对三唑类交叉耐药。艾沙康唑是对常见念珠菌分离株活性最强的三唑类药物。除2株对棘白菌素交叉耐药且对泊沙康唑也为NWT并被定义为多重耐药的光滑念珠菌外,棘白菌素对常见念珠菌属表现出良好活性。所有分离株对两性霉素B均为野生型。对于较不常见的菌种,季也蒙念珠菌对棘白菌素和氟康唑表现出高MIC,1株葡萄牙念珠菌对除两性霉素B外的所有抗真菌药物均表现出高MIC。在对三唑类耐药 的分离株中,10/14光滑念珠菌和6/23克柔念珠菌检测到ERG11突变,而21/23热带念珠菌表现出ERG11过表达。在25株对三唑类耐药的白色念珠菌分离株中,分别有14株、13株和8株表现出CDR1、CDR2和MDR1过表达,5株携带ERG11突变,2株对棘白菌素耐药的分离株携带FKS1基因的S663P突变。总体而言,CARST -真菌研究表明,尽管白色念珠菌仍然是最主要的菌种,但非白色念珠菌属占比很高。光滑念珠菌和克柔念珠菌中的三唑类耐药情况值得关注。白色念珠菌和较不常见酵母菌的多重耐药分离株不断出现。